Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by T Ohno
Phase I/Ii Study of S-1 Combined With Paclitaxel in Patients With Unresectable and/or Recurrent Advanced Gastric Cancer
British Journal of Cancer
Cancer Research
Oncology
Successful Prevention of Hematological Relapse for a Patient With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia After Allogeneic Bone Marrow Transplantation by Donor Leukocyte Infusion
Bone Marrow Transplantation
Transplantation
Hematology
Related publications
A Phase I/Ii Study of Poziotinib Combined With Paclitaxel and Trastuzumab in Patients With HER2-positive Advanced Gastric Cancer
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
A Phase I Study of Napabucasin Plus Paclitaxel for Japanese Patients With Advanced/Recurrent Gastric Cancer
In Vivo
Biochemistry
Medicine
Genetics
Pharmacology
Molecular Biology
Phase I/Ii Studies of Combination Chemotherapy With S-1 and Platinum in Patients With Previously Untreated Metastatic or Recurrent Gastric Cancer
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
Preoperative Chemoradiotherapy Using S-1 Combined With Celecoxib for Advanced Lower Rectal Cancer: Phase I/Ii Study
Journal of the Anus, Rectum and Colon
Docetaxel Versus Paclitaxel Combined With 5-Fu and Leucovorin in Advanced Gastric Cancer: Combined Analysis of Two Phase II Trials
Cancer Research and Treatment
Cancer Research
Oncology
A Retrospective Study of the Safety and Efficacy of Paclitaxel Plus Ramucirumab in Patients With Advanced or Recurrent Gastric Cancer With Ascites
BMC Cancer
Cancer Research
Oncology
Genetics
Docetaxel and Cisplatin in Patients With Advanced Gastric Cancer: Results of Japanese Phase I/Ii Study
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
Combination Chemotherapy With Irinotecan and Cisplatin in Pretreated Patients With Unresectable or Recurrent Gastric Cancer
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
A Phase I Trial of Dasatinib, an SRC-Family Kinase Inhibitor, in Combination With Paclitaxel and Carboplatin in Patients With Advanced or Recurrent Ovarian Cancer
Clinical Cancer Research
Cancer Research
Oncology
